ISSN 0975-3583

Journal of Cardiovascular Disease Research

    Predictive indications, clinical and biochemical features, and risk factors for ventilator-associated pneumonia

    Dr. Naga Lakshmi Katragadda, Dr. D Markandeyulu, Dr. G Suryanarayana Murthy, Dr. Kiran Mathangi, Dr. Abdul Arafath P
    JCDR. 2022: 893-898


    Associated with the Ventilator Patients are deemed to have had pneumonia if they experience pneumonia 48 hours after being intubated. Due to factors like hospital stays and deaths, it is very troublesome and expensive. Within the first five days after being intubated, 3% of patients are thought to develop VAP. Methods: The Department of Pulmonary Medicine and General Medicine, Government General Hospital Kakinada between August 2021 to February 2022. a tertiary referral facility for pulmonary medicine in Tamil Nadu, served as the site of this prospective observational study. This investigation took place between. August 2021 to February 2022 Results: We took these steps to ensure that none of the information we gathered was harmed in any way because we wanted to understand the clinical and biological profile of VAP in our ICUs. An average age of 45 was found among the study's participants. After intubation, pneumonia caused by the use of a ventilator usually took 7 days to manifest. They stayed in the hospital for 23 days total, on average, and averaged 14 days. Only 69 people had their levels of procalcitonin tested. In response to their request, one patient was taken out of the critical care unit (ICU) before their course of treatment was complete. Conclusion: Patients on ventilation who had normal chest x-rays at the time of intubation are more likely to experience late-onset VAP or late VAP. The most common microbes are Acinetobacter, Pseudomonas, and Klebsiella. The results were unaffected by the prevalence of resistant species over sensitive ones.


    » PDF

    Volume & Issue

    Volume 13 Issue 3